Dermira, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2010-01-01
- Employees
- 333
- Market Cap
- -
- Website
- http://www.dermira.com
Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Olumacostat Glasaretil Gel, 5.0%
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Dermira, Inc.
- Target Recruit Count
- 748
- Registration Number
- NCT03127956
- Locations
- 🇺🇸
Avant Research Associates, LLC, Guntersville, Alabama, United States
🇺🇸Advanced Research Associates, Glendale, Arizona, United States
🇺🇸Alliance Dermatology & MOHS Center, Phoenix, Arizona, United States
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Olumacostat Glasaretil Gel, 5.0%Other: Olumacostat Glasaretil Gel, Vehicle
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Dermira, Inc.
- Target Recruit Count
- 744
- Registration Number
- NCT03073486
- Locations
- 🇺🇸
Avant Research Associates, LLC, Guntersville, Alabama, United States
🇺🇸Advanced Research Associates, Glendale, Arizona, United States
🇺🇸Dermatology Trial Associates, Bryant, Arkansas, United States
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
- Conditions
- Acne Vulgaris
- Interventions
- Drug: Olumacostat Glasaretil Gel, 5.0%Other: Olumacostat Glasaretil Gel, Vehicle
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Dermira, Inc.
- Target Recruit Count
- 759
- Registration Number
- NCT03028363
- Locations
- 🇺🇸
Alliance Dermatology & MOHS Center, Phoenix, Arizona, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸Dermatology Research Associates, Los Angeles, California, United States
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
- First Posted Date
- 2015-04-30
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Dermira, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT02431052
- Locations
- 🇺🇸
Coastal Clinical Research, Inc., Mobile, Alabama, United States
🇺🇸T. Joseph Raoof, MD, Inc., Encino, California, United States
🇺🇸University Clinical Trials, Inc., San Diego, California, United States
A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- Dermira, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT01993433
- Locations
- 🇨🇦
Clinique Médicale Dr Isabelle Delorme, Drummondville, Quebec, Canada
🇨🇦Innovaderm Research, Inc, Montreal, Quebec, Canada
- Prev
- 1
- 2
- Next